¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"non respiratory acidosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • non-lysosomal proteinase
    ºñ¿ëÇØ¼Òü´Ü¹éºÐÇØÈ¿¼Ò, ºñ¸®¼ÒÁ»´Ü¹éºÐÇØÈ¿¼Ò
  • non-neurogenic neurogenic bladder
    ºñ½Å°æ½Å°æ¼º¹æ±¤
  • non-neurogenic neuropathic bladder
    ºñ½Å°æ½Å°æº´¼º¹æ±¤
  • non-proprietary name
    ÀϹݸí
  • non-Q wave
    ºñQÆÄ
  • non-rapid eye movement
    ºñ±Þ¼Ó¾È±¸¿îµ¿
  • non-small cell carcinoma
    ºñ¼Ò¼¼Æ÷¾ÏÁ¾
  • renal acidosis
    ½ÅÀ强»êÁõ
  • renal tubular acidosis
    ÄáÆÏ¿ä¼¼°ü»êÁõ, ½Å¼¼°ü»êÁõ
  • uremic acidosis
    ¿äµ¶¼º»êÁõ
  • uncompensated acidosis
    ºñº¸Á¤»êÁõ
  • acute respiratory distress syndrome
    ±Þ¼ºÈ£Èí°ï¶õÁõÈıº
  • adult respiratory distress syndrome
    ¼ºÀÎÈ£Èí°ï¶õÁõÈıº
  • hypoxemic respiratory failure
    Àú»ê¼ÒÇ÷ÁõÈ£Èí±â´É»ó½Ç, Àú»ê¼ÒÇ÷ÁõÈ£ÈíºÎÀü
  • idiopathic respiratory distress
    Ư¹ßÈ£Èí°ï¶õ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory insufficiency
    È£Èí±â´ÉºÎÁ·
  • respiratory mucosa
    È£ÈíÁ¡¸·
  • respiratory nerve
    È£Èí½Å°æ
  • respiratory organ
    È£Èí±â°ü
  • respiratory obstruction
    ±âµµ¸·Èû, È£ÈíÆó¼â
  • respiratory quotient
    È£ÈíÁö¼ö, È£Èí»ó¼ö
  • respiratory rate
    È£Èí¼öÈ£Èí·ü
  • respiratory substrate
    È£Èí±âÁú
  • respiratory system
    È£Èí°èÅë
  • respiratory stimulant
    È£ÈíÀÚ±ØÁ¦
  • respiratory stenosis
    ±âµµÇùÂø(Áõ)
  • respiratory standstill
    È£ÈíÁ¤Áö
  • respiratory distress syndrome
    È£Èí°ï¶õÁõÈıº
  • respiratory disturbance syndrome
    È£ÈíÀå¾ÖÁõÈıº
  • severe acute respiratory syndrome
    ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • non-neuropathic psychologic bladder
    ºñ½Å°æº´½É¸®Àû¹æ±¤
  • non-equilibratory coordination
    ºñ±ÕÇüÁ¶Á¤¿îµ¿
  • non-insulin-dependent diabetes
    ºñÀν¶¸°ÀÇÁ¸´ç´¢º´
  • non-healing granuloma
    ¾Ç¼ºÀ°¾ÆÁ¾
  • non enhanced image
    ºñÁ¶¿µÁõ°­¿µ»ó
  • non-Hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-rapid eye movement
    ºñ±Þ¼Ó¾È±¸¿îµ¿
  • non compos mentis
    ½É½Å»ó½Ç»óÅÂ
  • non-lysosomal proteinase
    ºñ¸®¼Ò¼Ø´Ü¹éºÐÇØÈ¿¼Ò
  • non-proprietary name
    ÀϹݸí
  • non-vibrating tinnitus
    ºñÁøµ¿±Í¿ï¸², ºñÁøµ¿À̸í
  • respiratory alkalosis
    È£Èí¾ËÄ«¸®Áõ
  • respiratory apparatus
    È£Èí±â°ü
  • respiratory arrest
    È£ÈíÁ¤Áö
  • respiratory arrhythmia
    È£ÈíºÎÁ¤¸Æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • relative acidosis
    »ó´ëÀû »êÁõ(ßÓÓßîÜß«ñø).
  • renal acidosis
    ½Å¼º»êÁõ.
  • renal acidosis
    ½Å¼º»êÁõ(ãìàõß«ñø)
  • IRDNI=£¾idiopathic respiratory distress of the newborn infant
    ½Å»ý¾Æ Ư¹ß¼º È£Èí°ï¶õÁõ, À¯¸®Áú¸·Áõ.
  • RDS=£¾respiratory distress syndrome
    È£Èí°ï¶õÁõÈıº.
  • TWAR strain => Taiwan acute respiratory strain
    ŸÀ̿ϱ޼º È£Èí±â±ÕÁÖ, TWAR ±ÕÁÖ
  • Taiwan acute respiratory strain
    ŸÀ̿ϱ޼º È£Èí±â±ÕÁÖ
  • accessory respiratory muscle
    º¸Á¶È£Èí±Ù(ÜÍð¾û¼ýåÐÉ)
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • acute respiratory illness =ARI
    ±Þ¼º È£Èí±âº´.
  • acute respiratory illness =ARI
    ±Þ¼º È£Èí±âº´.
  • adult respiratory distress syndrome
    ¼ºÀμº È£Èí°ï¶õÁõÈıº(à÷ìÑàõû¼ýåÍÝÑññøý¦ÏØ).
  • adult respiratory distress syndrome(ards)
    ¼ºÀμºÈ£Èí°ï¶õÁõÈıº(à÷ìÑàõû¼ýåÍÝÑññøý¦ÏØ)
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dilution acidosis
    Èñ¼®¼º»êÁõ.
  • gaseous acidosis
    °¡½º¼º »êÁõ(¡­»êÁõ).
  • gaseous acidosis
    °¡½º¼º »êÁõ(¡­ß«ñø).
  • hyperchloremic acidosis
    °í¿°¼ÒÇ÷»êÁõ
  • hypoxic acidosis
  • inanition acidosis
    ±â¾Æ(¼º)»êÁõ.
  • lactic acidosis
    ¶ôÆ®»ê»ê(¼º)Áõ
  • lactic acidosis
    ¶ôÆ®»ê»ê(¼º)Áõ, À¯»ê»êÁõ, À¯»êÁõ.
  • lactic acidosis
    À¯»ê»êÁõ
  • lactic acidosis
    ¶ôÆ®»ê»ê(¼º)Áõ, À¯»ê»êÁõ, À¯»êÁõ.
  • metabolic acidosis
    ´ë»ç¼º »êÁõ, ´ë»ç¼º ¾Æ ½Ãµµ½Ã½º.
  • metabolic acidosis
    ´ë»ç¼º ½ÅÁõ(ÓÛÞóàõ ãìñø)
  • metabolic acidosis
    ´ë»ç¼º»êÁõ
  • oxidosis =acidosis
    »ê¼ºÁõ(ß«àõñø).
  • oxyosis =acidosis
    »êÇ÷Áõ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory assembly
    È£Èí ¾Æ
  • respiratory burst
    È£Èí ±ÞÁõ(Ðáñø)
  • respiratory chain
    È£Èí ¿¬¼â(Ö§áð)
  • respiratory chain phosphorylation
    È£Èí¿¬¼â ÀλêÈ­(×òß«ûù)
  • respiratory complex
    È£Èí º¹ÇÕü(ÜÜùêô÷)
  • respiratory control
    È£Èí Á¶Àý(ðàï½)
  • respiratory-control index
    È£Èí Á¶Àý Áö¼ö(ò¦â¦)
  • respiratory enzyme
    È£Èí È¿¼Ò(ý£áÈ)
  • respiratory enzyme complex
    È£Èí È¿¼Ò º¹ÇÕü(ÜÜùêô÷)
  • respiratory inhibitor
    È£Èí ÀúÇØÁ¦(îÁúªð¥)
  • respiratory pigment
    È£Èí »ö¼Ò(ßäáÈ)
  • respiratory poison
    È£Èí µ¶¼Ò(Ô¸áÈ)
  • respiratory protein
    È£Èí ´Ü¹éÁú(Ó±ÛÜòõ)
  • respiratory quotient
    È£Èí·ü(û¼ýå×Ë)
  • respiratory reduction
    È£Èí¼º ȯ¿ø(û¼ýåàõü½êª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory bronchiole
    È£Èí±â°ü¼¼Áö, È£Èí¼º¼¼±â°üÁö
  • respiratory capacity
    È£Èí¿ë·®, ÆóȰ·®
  • respiratory center
    È£ÈíÁßÃß
  • respiratory dead space
    È£Èí¼º¹«È¿°ø°£
  • respiratory disease
    È£Èí±âº´, È£Èí°ï¶õ
  • respiratory distress syndrome
    È£Èí°ï¶õÁõÈıº
  • respiratory disturbance
    È£ÈíÀå¾Ö
  • respiratory failure
    È£ÈíºÎÀü
  • respiratory function
    È£Èí±â´É
  • respiratory function test
    È£Èí±â´É°Ë»ç
  • respiratory gating
    È£Èíµ¿±â
  • respiratory insufficiency
    È£Èí(±â´É)ºÎÀü
  • respiratory obstruction
    ±âµµÆó¼â, È£ÈíÆó¼â
  • respiratory ordered phase encoding
    È£Èí¼øÀ§»óºÎȣȭ
  • respiratory organ
    È£Èí±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
non-REM non-rapid eye movement [sleep]
RR   1) Respiratory Rate
  2) Relative Risk; ºñ±³À§Çèµµ
    &n...
Acid. Acidosis
DKA Diabetic Keto-Acidosis
MELAS Syndrome   1. Mitochondrial Encephalomyopathy
  2. Lactic Acidosis
  3. S...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RTA Renal Tubular Acidosis
LAT lactic acidosis threshold
MELAS myopathy, encephalopathy, lactic acidosis and stroke like episodes
npRQ Non protein respiratory quotient
NANB C/non-A, non-B
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • respiratory bag
    È£Èí ³¶
  • respiratory bronchiolitis
    È£Èí ¼¼±â°üÁö¿°
    ÀþÀº Èí¿¬°¡¿¡¼­ º¼ ¼ö ÀÖ´Â ¼Ò±âµµ ÁúȯÀÌ´Ù. ÀÓ»óÀûÀ¸·Î³ª ¹æ»ç¼± »çÁø»ó Ư¹ß¼º °£Áú¼º Æó ¼¶À¯È­Áõ°ú À¯»çÇÏ´Ù. ±âħ, È£Èí °ï¶õ, ûÁø»ó ¼öÆ÷À½ µîÀÌ Æ¯Â¡ÀÌ´Ù. Ư¹ß¼º °£Áú¼º Æó ¼¶À¯È­Áõ¿¡¼­ º¸ÀÌ´Â ÆóÀ¯¼øµµÀÇ °¨¼Ò´Â ÀÌ Áúȯ¿¡¼­´Â º¼ ¼ö ¾øÀ¸¸ç, °£È¤ °³Èä Æó »ý°Ë¿¡¼­ ¹ß°ßµÇ´Âµ¥ Á¶Á÷ °Ë»ç»ó ¸»´Ü ¼¼±â°üÁö¿Í È£Èí ¼¼±â°üÁö¿¡ Ư¡ÀûÀÎ ÀÌÇü¼º°ú »ö¼Ò Ä§Âø ¼¼Æ÷, ´ë½Ä ¼¼Æ÷¿¡ ÀÇÇÑ ÆóÆ÷, ÆóÆ÷°ü, ¸»´Ü ¹× È£Èí ¼¼±â°üÁöÀÇ ±âµµ ÃæÀüÀ» º¼ ¼ö ÀÖ´Ù.
  • respiratory center
    È£Èí ÁßÃß
  • respiratory dead space
    È£Èí¼º ¹«È¿ °ø°£
  • respiratory depression
    È£Èí ÀúÇÏ
  • respiratory distress syndrome
    È£Èí °ï¶õ ÁõÈıº
  • respiratory disturbance
    È£Èí Àå¾Ö
  • respiratory excitant
    È£Èí ÈïºÐ ¾à
  • respiratory function
    È£Èí ±â´É
  • respiratory gating
    È£Èí µ¿±â
  • respiratory movement
    È£Èí ¿îµ¿
  • respiratory muscle
    È£Èí±Ù
  • respiratory nerve
    È£Èí ½Å°æ
  • respiratory ordered phase encoding
    È£Èí ¼øÀ§ »ó ºÎȣȭ
  • respiratory paralysis
    È£Èí ¸¶ºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
diabetic acidosis Decreased pH and bicarbonate concentration in the body fluids caused by accumulation of ketone bodies in diabetes mellitus.
(05 Mar 2000)
osteopetrosis with renal tubular acidosis <syndrome> An inherited deficiency of carbonic anhydrase II that results in osteopetrosis and metabolic acidosis.
Synonym: osteopetrosis with renal tubular acidosis.
(05 Mar 2000)
uncompensated acidosis An acidosis in which the pH of body fluids is subnormal, because restoration of normal acid-base balance is not possible or has not yet been achieved.
(05 Mar 2000)
lactic acidosis <biochemistry, physiology> Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolised.
It may occur spontaneously or in association with diseases such as diabetes mellitus, leukaemia, or liver failure.
(25 Jun 1999)
abortifacient agents, non-steroidal Non-steroidal chemical compounds with abortifacient activity.
(12 Dec 1998)
acute non-lymphocytic leukaemia <haematology> A form of leukaemia which is characterised by the proliferation of immature bone marrow precursor cells in the marrow and immature white blood cells (granulocytes) in the bloodstream. Occurs primarily in adults and in infants under 1 year of age. Complications include abnormal bleeding and susceptibility to infections.
Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains.
Trisomy-8 is the most common cytogenetic abnormality observed, followed by monosomy-7 and monosomy-5. Approximately 8% of cases show trisomy-8, mostly in AML (M1), AM (M4) and acute monocytic leukaemia (M5). Many pre-leukaemic conditions, acute non-lymphocytic leukaemia and secondary leukemia show monosomy-7 or deletion of the long arm of chromosome 7.
Treatment includes chemotherapy and/or bone marrow transplant.
Acronym: ANLL
Incidence: 2.5 cases per 100,000 (all ages).
Origin: Gr. Haima = blood
(07 Apr 1998)
analgesics, non-narcotic Drugs that have principally analgesic, antipyretic, and anti-inflammatory actions. They do not bind to opioid receptors and are not classified under the controlled substances act.
(12 Dec 1998)
anti-inflammatory agent, non-steroidal Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain nsaids also may inhibit lipoxygenase enzymes or phospholipase c or may modulate T-cell function. (ama drug evaluations annual, 1994, p 1814-5)
(12 Dec 1998)
auctorum non Not of authors.
(09 Jan 1998)
cancer, lymphoma, non-hodgkin's A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy.
(12 Dec 1998)
carcinoma, non-small-cell lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. They are dealt with collectively because of the shared properties of poor response to conventional chemotherapy and the potential for cure with surgical resection in a fraction of patients.
(12 Dec 1998)
Gomori's non-specific acid phosphatase stain <technique> A method in which formalin-fixed frozen sections are incubated in a substrate containing sodium beta-glycerophosphate and lead nitrate at pH 5.0; the insoluble lead phosphate produced is treated with ammonium sulfide to give a black lead sulfide.
(05 Mar 2000)
Gomori's non-specific alkaline phosphatase stain <technique> A calcium-cobalt sulfide method using frozen sections or cold acetone-or formalin-fixed paraffin sections, plus sodium beta-glycerophosphate as a substrate at pH 9.0 to 9.5 with Mg++ as activator; calcium ions precipitate the liberated phosphate, cobalt salt replaces the calcium phosphate, and ammonium sulfide converts the product to a black cobalt sulfide.
(05 Mar 2000)
chromosomal proteins, non-histone Nucleoproteins which in contrast to histones are acid insoluble. They are involved in chromosomal functions; e.g. They bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens.
(12 Dec 1998)
prescriptions, non-drug Written directions for the preparation, administration, or application of a non-drug remedy. This includes prescriptions for corrective lenses, self-help and orthopedic devices, and physical therapy and rehabilitation measures.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • non est
    Á¸ÀçÇÏÁö ¾Ê´Â;ºÎÀçÀÇ
  • non est inventus
    º»ÀμÒÀç ºÒ¸í
  • non liquet
    ÀçÆÇ ¿¬±âÀÇ ¹è½ÉÆò°á
  • non obs(t).
    non obstante
  • non obstante
    ..¿¡µµ ºÒ±¸Çϰí
  • non placet
    (±³È¸,´ëÇÐÀÇ Áýȸ¿¡¼­)ÀÌÀÇ;¹Ý´ëÅõÇ¥
  • non plus ultra
    NE PLUS ULTRA
  • non possumus
    ¹«´É·Â(ºÒ´É)ÀÇ ½Åû
  • non prosequitur
    (¼Ò¼ÛÀýÂ÷¸¦ Ÿ¸È÷ ÇÏ´Â ¿ø°í¿¡ ´ëÇÑ)ÆÐ¼ÒÆÇ°á
  • non seq.
    non sequitur
  • non sequitur
    ±×¸©µÈ °á·Ð
  • non troppo
    Áö³ªÄ¡Áö ¾Ê°Ô;¾Ë¸Â°Ô
  • non-
    ¾Ê´Ù;¾Æ´Ï´Ù
  • non-
    (ÀÚÀ¯·ÎÀÌ ¸í»ç,Çü¿ë»ç,ºÎ»ç¿¡ ºÙ¿©¼­);ºñ;ºÒ;¹«ÀÇ ¶æÀ» ³ªÅ¸³¿
  • sine qua non
    ÇÊ¿ä Á¶°Ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á